Circulating Betatrophin Levels Are Increased in Patients With Type 2 Diabetes and Associated With Insulin Resistance
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
CONTEXT: Betatrophin has recently attracted increasing interests as a potential β-cell regenerative therapy in diabetes. However, differences in betatrophin profiles in patients with type 2 diabetes mellitus (T2DM) remain unclear. OBJECTIVE: The objective of the study was to examine circulating betatrophin levels in subjects with different glucose tolerance status and its correlation with insulin resistance. DESIGN, SETTING, AND PARTICIPANTS: Serum betatrophin levels were measured using an ELISA in age-, sex-, body mass index-, and blood lipid-matched subjects with normal glucose tolerance (n = 137), isolated impaired fasting glucose (n = 69), isolated impaired glucose tolerance (n = 120), and newly diagnosed T2DM (n = 112) from the Risk Evaluation of Cancers in Chinese Diabetic Individuals: A Longitudinal study. RESULTS: Serum betatrophin levels were elevated in patients with T2DM compared with subjects with normal glucose tolerance, isolated impaired fasting glucose, or isolated impaired glucose tolerance (798.6 ± 42.5 vs 692.7 ± 29.0, P < .05, vs 682.7 ± 43.0, P < .05, vs 646.8 ± 34.3 pg/mL, P < .01). Betatrophin levels positively correlated with the index of homeostasis model assessment of insulin resistance (partial r = 0.11); inversely correlated with quantitative insulin sensitivity check index (partial r = -0.11), the Gutt insulin sensitivity index (partial r = -0.12), and the Matsuda insulin sensitivity index (partial r = -0.11) after controlling for age, sex, body mass index, and blood lipid in all participants (all values of P < .05). CONCLUSION: Circulating betatrophin levels are increased in patients with T2DM and associated with indexes of insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is substantiated by the fact that betatrophin levels are higher in T2DM patients,182, 183, 184 although they were lower in one study.185”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [183]
Citations
Cites
1 retracted
RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation
Yi, P., Park, J.-S., & Melton, D. A. (2013) · Cell · doi:10.1016/j.cell.2013.04.008 · Cited by 449
RetractedMatthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
Atypical angiopoietin-like protein that regulates ANGPTL3
Quagliarini, F., Wang, Y., Kozlitina, J., Grishin, N. V., Hyde, R., Boerwinkle, E., Valenzuela, D. M., Murphy, A. J., Cohen, J. C., & Hobbs, H. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217552109 · Cited by 409
Wang, Y., Quagliarini, F., Gusarova, V., Gromada, J., Valenzuela, D. M., Cohen, J. C., & Hobbs, H. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315292110 · Cited by 317
Zhang, R. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.038 · Cited by 311
Ren, G., Kim, J. Y., & Smas, C. M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00084.2012 · Cited by 261
Evaluation of insulin sensitivity in clinical practice and in research settings
Monzillo, L. U., & Hamdy, O. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.dec.397-412 · Cited by 259
Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity
Fu, Z., Berhane, F., Fite, A., Seyoum, B., Abou-Samra, A. B., & Zhang, R. (2014) · Scientific Reports · doi:10.1038/srep05013 · Cited by 232
Fenzl, A., Itariu, B. K., Kosi, L., Fritzer-Szekeres, M., Kautzky-Willer, A., Stulnig, T. M., & Kiefer, F. W. (2014) · Diabetologia · doi:10.1007/s00125-014-3208-x · Cited by 165
Cited by
Items 101–132 of 132
Xu, F., Shen, L., Yang, Y., Kong, L., Zu, W., Tian, D., Xuanchao, C., & Huang, G. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s411483 · Cited by 5
Self-citationGarrett, J. M., McCormick, J. J., King, K. E., Meade, R. D., Boulay, P., Sigal, R. J., O’Connor, F. K., & Kenny, G. P. (2025) · Physiological Reports · doi:10.14814/phy2.70411 · Cited by 5
Insulin resistance and adaptation of pancreatic beta cells during pregnancy
Zielińska-Maciulewska, A., Kretowski, A. J., & Szelachowska, M. (2018) · Clinical Diabetology · doi:10.5603/dk.2018.0022 · Cited by 4
“Bierze ona udział w metabolizmie lipidów i jest związana z insulinoopornością [39, 40].”
The potential role of betatrophin in hepatocellular carcinoma and metabolic syndrome
Susanto, H., Aulanni’am, A., Wang, C. H., Wuragil, D. K., Handaya, A. Y., Pertiwi, M. P., & Nisa, S. A. R. (2019) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1146/1/012003 · Cited by 4
Chen, C.-C., Susanto, H., Chuang, W.-H., Liu, T.-Y., Arivajiagane, A., & Wang, C.-H. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0538-2 · Cited by 4
Positive correlation of ANGPTL8 expression in human visceral adipose tissue with body mass index
Chen, S.-M., Huang, T., Lee, W., Chuang, L., & Chang, T. (2024) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.12.018 · Cited by 3
Susanto, H., Taufiq, A., Listyorini, D. I., Handaya, A. Y., & Pertiwi, M. P. (2019) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/515/1/012054 · Cited by 3
New insights into ANGPTL8 in modulating the development of cardio-metabolic disorder diseases
Su, X., Zhang, G., Cheng, Y., & Wang, B. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06335-8 · Cited by 3
Self-citationAssociation between circulating betatrophin levels and T2DM: a meta-analysis
Yuquan, Z. H. A. N. (2024) · Minerva Endocrinology · doi:10.23736/s2724-6507.23.04073-3 · Cited by 2
Odyjewska, E., Kupińska, M., Jamiołkowska‐Sztabkowska, M., Bossowski, A. T., & Głowińska‐Olszewska, B. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1602777 · Cited by 2
Leutner, M., Matzhold, C., Bellach, L., Deischinger, C., Stefan Thurner, A., Klimek, P., & Kautzky‐Willer, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-70075-1 · Cited by 2
Timurkaan, M., & Ayyıldız, H. (2022) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1038569 · Cited by 2
Udupa, S. T., Shivashankara, A. R., Suchetha Kumari, N., Shetty, S. S., & D’Cunha, P. (2022) · Biomedicine · doi:10.51248/.v42i4.1325 · Cited by 2
“There are contradicting results from the studies on betatrophin and IR, some studies have suggested that circulating betatrophin levels are elevated in T2DM as well as type 1 diabetes (17-19), while others reported that betatrophin levels were reduced in subjects with diabetes (20).”
ResultAlduraywish, A. A. (2017) · Journal of Endocrinology and Metabolism · doi:10.14740/jem405w · Cited by 2
Molecular mechanisms of type 2 diabetes mellitus in Chinese
Wang, W., & Lu, J. (2018) · Scientia Sinica Vitae · doi:10.1360/n052018-00043 · Cited by 3
Salama, M. M., Kabiel, W. A. Y., Hana, S. S., & Mohamed, G. A. (2020) · Egyptian Liver Journal · doi:10.1186/s43066-020-00039-7 · Cited by 2
“In agreement with previous results [7, 9], candidates who had IR had higher serum betatrophin levels than candidates without IR.”
BackgroundResultSusanto, H., Sholeh, M., Endharti, A. T., Malek, N. A. N. N., Firdaus, S. R. A., Handaya, A. Y., & Taufiq, A. (2024) · HAYATI Journal of Biosciences · doi:10.4308/hjb.32.2.414-425 · Cited by 1
Cinar, R., Günday, Ö. K., Kahraman, A., & Yılmazer, M. (2025) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2025rbgo86 · Cited by 1
Serum Betatrophin: What It Shows and How It Alters in Gestational Diabetes Mellitus
Melekoğlu, R., & Çelik, E. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_19-1 · Cited by 1
Study of Serum Betatrophin Level in The Patients of Type 2 Diabetes Mellitus
El-Ghandour, A. H., El-Bendary, A. S., Shahba, A., & Soliman, G. A. (2019) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2019.28682 · Cited by 1
Serum Betatrophin: What It Shows and How It Alters in Gestational Diabetes Mellitus
Melekoğlu, R., & Çelik, E. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_19 · Cited by 4
Arıkan, F. B., Ulaş, M., Üstündağ, Y., Boyunağa, H., & Badem, N. D. (2023) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2022-0104 · Cited by 2
Bao, Y. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.06.013
Insulinooporność i adaptacja komórek beta trzustki podczas ciąży
Zielińska-Maciulewska, A., Krętkowski, A., & Szelachowska, M. (2018) · Via Medica Journals
Wyższe stężenie betatrofiny u pacjentów z noworozpoznaną cukrzycą
Maciulewski, R., Zielińska-Maciulewska, A., Siewko, K., Kozłowska, G., Lipińska, D., Milewska, A. J., Górska, M., Kretowski, A. J., & Szelachowska, M. (2019) · Clinical Diabetology · doi:10.5603/dk.2019.0002
Study of serum betatrophin level as a biochemical marker in patients with type 2 diabetes mellitus
Abbas, N., ABOUELMAGD, M. M., Marzouk, H. F. A., & Elghaba, M. (2022) · International Journal of Medical Arts · doi:10.21608/ijma.2022.99440.1377 · Cited by 3
“[26, 22] .”
Liu, Y., Yuan, H., Wang, A., Wang, S., Xu, X., Hu, J., Shen, J., Hu, Y., Li, X., Li, N., et al. (2024) · medRxiv · doi:10.1101/2024.06.23.24309370
Susanto, H. (2025) · AIP conference proceedings · doi:10.1063/5.0234671
Gümüşkaya, P. Ö., Yıldırım, E., Altun, Ö., & Uzun, H. (2025) · Medicina · doi:10.3390/medicina61040708
Shehab, M., Al-Fajri, S., Alanqar, A., Alborom, M., Alrashed, F., Alshammaa, F., Alfadhli, A., Devarajan, S., Al‐Khairi, I., Cherian, P., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14145006
“This is due to complex interactions with glucose metabolism, triglycerides, and increases in beta cell proliferation and insulin secretion [19–25].”
Zou, H., Xu, Y., Meng, X., Li, D., Chen, X., Du, T., Yang, Y., Chen, Y., 邵诗颖, Yuan, G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14843190
Self-citationUrsoleo, P. (2015) · Electronic Theses and Dissertations Repository (University of Pisa)
Metadata
- Authors
- Chen, X., Lu, P., He, W., Zhang, J., Liu, L., Yang, Y., Liu, Z., Xie, J., Shao, S., Du, T., Su, X., Zhou, X., Hu, S., Yuan, G., Zhang, M., Zhang, H., Liu, L., Wang, D., & Yu, X.
- Affiliations
- Tongji Hospital (CN)
- Corresponding author
- Yu, Xuefeng
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-01
- Volume
- 100
- Issue
- 1
- Pages
- E96-E100
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2141915302
- Cited by
- 129
- References
- 18
- Citations by year
- 2025: 7 · 2024: 7 · 2023: 6 · 2022: 11 · 2021: 11 · 2020: 14 · 2019: 7 · 2018: 14 · 2017: 18 · 2016: 21 · 2015: 13
- FWCI
- 13.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- betatrophin, type 2 diabetes, insulin resistance, impaired fasting glucose, impaired glucose tolerance, glucose tolerance, insulin sensitivity index, beta cell regeneration, circulating biomarkers
- MeSH terms
- Angiopoietin-like Proteins, Angiopoietin-Like Protein 8, Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Longitudinal Studies, Male, Middle Aged, Prediabetic State, Glucose Intolerance, Peptide Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.